Clinical Study
The Effects of Continuous Blood Purification for SIRS/MODS Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
| Study or subgroup | CVVH | Control | | Std. mean difference | Std. mean difference | Mean | SD | Total | Mean | SD | Total | Weight | IV, fixed, 95%CI | IV, fixed, 95%CI |
| 1.1.1 after 3 days | | | | | | | | | | Liu et al. 2003 [10] | 22 | 78.58 | 24 | 46 | 89.74 | 26 | 46.3% | −0.28 (−0.84, 0.28) | Zhang et al. 2008 [15] | 8.99 | 4.59 | 30 | 13.43 | 9.3 | 30 | 53.7% | −0.60 (−1.12, −0.08) | Subtotal (95%Cl) | | | 54 | | | 56 | 100.0% | −0.45 (−0.83, −0.07) | Heterogeneity: Chi-square = 0.67, df = 1 ( = 0.41); = 0% | | | | | | | | | Test for overall effect = 2.32 ( = 0.02) | | | | | | | | | 1.1.2 after 7 days
| | | | | | | | | Liu et al. 2003 [10] |
31
|
78.58
|
24
|
32
|
93.58
| 26 | 65.0% | −0.01 (−0.57, 0.54) | Zhang et al. 2008 [15] |
−18.57
|
4.44
|
30
|
−5.34
|
4.16
| 30 | 35.0% | −3.04 (−3.79, −2.28) | Subtotal (95%Cl) | | | 54 | | | 56 | 100.0% | −1.07 (−1.52, −0.62) | Heterogeneity: Chi-square = 39.93, df = 1 ( < 0.00001); = 97% | | | | | | | | | Test for overall effect: = 4.69 ( < 0.00001) | | | | | | | | | Test for subgroup differences: Chi-square = 4.28, df = 1 ( = 0.04), = 76.7% | | | | | | | | |
|
|